InsiderFlow

EXOZ

eXoZymes, Inc.$4.15+0.02 (+0.48%)
Prev Close$4.13·MCap$63.7M·P/E—·Vol223·Yield—
▲

Buys (12M)

1

$6.4K

▼

Sells (12M)

2

$34.9K

◆

Net Activity

Net Seller

$28.4K

●

Active Insiders

3

last 12 mo

Over the past 12 months, insider activity at eXoZymes, Inc. (EXOZ) has been dominated by selling, with 1 insider purchase totaling $6.4K and 2 insider sales totaling $34.9K. The most recent insider transaction was by Perriman Damien Alan (officer: Chief Commercial Officer), who sold $19.4K worth of shares on Oct 26, 2026. eXoZymes, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $63.7M.

EXOZ Insider Trading Activity

DateInsiderTypeValue
Oct 26, 2026 Perriman Damien AlanSell$19.4K
Sep 2, 2026 Heltzen MichaelBuy$6.4K
Apr 10, 2026 Korman Tyler PazSell$15.4K
Jul 2, 2025 Heltzen MichaelBuy$10.6K
Jan 21, 2025 Heltzen MichaelBuy$20.3K
Nov 19, 2024 Heltzen MichaelBuy$22.0K

EXOZ Insider Buying Activity

The following table shows recent insider purchases of eXoZymes, Inc. (EXOZ) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Sep 2, 2026 Heltzen MichaelBuy$6.4K
Jul 2, 2025 Heltzen MichaelBuy$10.6K
Jan 21, 2025 Heltzen MichaelBuy$20.3K
Nov 19, 2024 Heltzen MichaelBuy$22.0K

EXOZ Insider Selling Activity

The following table shows recent insider sales of eXoZymes, Inc. (EXOZ) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Oct 26, 2026 Perriman Damien AlanSell$19.4K
Apr 10, 2026 Korman Tyler PazSell$15.4K

EXOZ Insiders

Perriman Damien Alan

officer: Chief Commercial Officer

Sold $19.4K
1 tradesLast: Oct 26, 2026
Heltzen Michael

officer: Chief Executive Officer

Bought $59.4K
4 tradesLast: Sep 2, 2026
Korman Tyler Paz

officer: Chief Scientific Officer

Sold $15.4K
1 tradesLast: Apr 10, 2026